A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711

NCT04135833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: BPI-7711
DRUG: BPI-7711
DRUG: Itraconazole
DRUG: Rifampicin

Sponsor

Beta Pharma, Inc.